J2 Ventures

J2 Ventures Partner Christine Keung shared her perspective on how national security is shaping the future of innovation at the MISSION 2044 New York Summit, alongside experts from IQT (In-Q-Tel), Graphika, and AerisLabs. The audience also got to hear how our portfolio company SkyFi is revolutionizing Earth intelligence with AI-driven analytics and seamless access to geospatial imagery. Luke Fischer and Kate van Dam showcased how SkyFi delivers actionable insights and drives impact for enterprises and government agencies worldwide. MISSION 2044 brings together founders, investors, defense primes, military leaders, policymakers, and thought leaders from the U.S., Europe, and global allies, to foster collaboration across technology ecosystems. We're proud to be a part of this community shaping the future of critical technologies. #Mission2044 #Innovation #NationalSecurity #DefenseTech #SpaceTech Dr. Markus Federle Grant W., John Kelly Amos Lahav Luke Fischer Kate van Dam

J2 Ventures is pleased to announce that Master Chief Petty Officer Adam Briley will be joining as our inaugural Defense Fellow! The J2 Defense Fellow is a one-year role designed to support outstanding individuals from the defense and intelligence communities, showcasing J2’s commitment to national security while benefiting from the operational expertise they bring. Adam shares his journey?in?his own words: "'You know what would be a good idea?' and 'If we only had…' are two of the most common statements?in?a special operations team room. Toward the end of my 24-year Navy SEAL career, I wanted to stop asking questions and start finding solutions by transitioning from operational leadership roles into research and development position for the U.S. Special Operations Command. There, I led technology teams to ensure mission success and safeguard special operators. My role also allowed me to collaborate with startups on product development, funding strategies, and transition pathways. Aside from the military, I've had the privilege of advising student teams MIT, Harvard, and the U.S. service academies on defense prototypes and hold board positions with non-profit organizations that assist special operators?in?transitioning into civilian careers. I have an MBA from Duke University's Fuqua School of Business and a Master's?in?Administrative Leadership from the University of Oklahoma. Becoming a J2 Defense Fellow is an immense opportunity that will allow me to continue my commitment to serving our warfighters by learning from and contributing to an incredible team focused on delivering value to national security."

The wins keep coming- congratulations to our portfolio company ōURA on their recent partnership with Dexcom and the closing of their series D at over $5B!

Today the "Q" in Q Station stood for QUANTUM! We were thrilled to show Thorlabs President Jennifer Cable Space Valley's strengths in quantum technologies. Special thank you to The University of New Mexico, New Mexico Institute of Mining and Technology, CNM Ingenuity, Sandia National Laboratories and Air Force Research Laboratory for letting us show you off! #spacevalley #spacevalleynm #spacevalleyusa #qstation #quantum

J2 Ventures is excited to lead the seed investment in Parallel Fluidics, the fastest microfluidic device manufacturer in the world! ?? Alongside Matt Blodgett (Praxis Ventures), Sebastian Caliri (8VC), and Larry Lukis (Protolabs founder and retired Chairman), we’re supporting Joshua G. and Andy Harris in their mission to revolutionize the scientific discovery process with the first on-demand microfluidic manufacturing platform. Microfluidics is transforming diagnostics, drug discovery, precision medicine, sequencing, and cell therapy, enabling tests at a microscopic scale for unprecedented speed, precision, and throughput. Parallel Fluidics is set to overcome design and supply chain barriers in this $32B market, projected to reach $117B by 2031. This $7M seed round will drive the expansion of Parallel Fluidics' advanced hardware and software solutions, enabling rapid design and production capabilities for researchers across life sciences. Congratulations to the entire Parallel Fluidics team! We’re excited to support your journey as you pave the way for scientific teams to accelerate innovation and discovery. #FundingAnnouncement #LifeSciences #Microfluidics #Innovation #Healthcare #VentureCapital

Investing in the future is something we can (and do) all get behind - happy #electionday, America!

?? Check out TechCrunch Equity to hear how 22-year-old Zander Brumbaugh, CEO of Gamebeast, is reshaping UGC (user-generated content) in gaming! Gamebeast empowers Roblox developers with A/B testing and LiveOps tools to update games seamlessly, no re-release required. With kids driving demand for virtual currency (think Robux, V-Bucks), UGC platforms like Roblox and Fortnite are only growing in popularity. Zander shares why he envisions UGC as the future of gaming and how Gamebeast’s dual-use tech potential across commercial and defense is paving the way for critical sectors in unexpected ways. ?? Thank you Rebecca Bellan for highlighting Zander's journey! #UGC #GamingInnovation #TechCrunch #Podcast #Roblox #Fortnite #VentureCapital #DualUse

Come check out our very own Christine Keung at the #mission2044newyorksummit! Christine will be speaking about #dualuse technologies drawing on her experiences across the public and private sector continuum. Mark your calendars and come watch in New York City!

Congratulations Tim Miller, Parth Patel, CISSP, and the entire Kusari team on releasing the Kusari Platform!! ???? By using Software Bill of Materials (SBOM) data—which is basically a list of all the software parts—the platform shows a timeline of the software to help spot potential issues. Kusari creates a clear, centralized view for teams in security, engineering, legal, finance, and compliance, making it easier to find security weaknesses, track open source licensing problems, and perform compliance checks quickly ?! #Cybersecurity #ProductLaunch #SBOM

Congratulations Micron Biomedical, Inc. For their #BWB award win for biotech innovation of the year! A needleless and more effective medicinal future is closer than we all think and J2 is grateful to be partnered with Micron in its mission to change how the world gets critical medicine. Matt Goldman Steven Damon Idean Marvasty